AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (November 7, 2007). doi:10.1152/ajprenal.00281.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/1/F161    most recent
00281.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Graciano, M. L
Right arrow Articles by Navar, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Graciano, M. L
Right arrow Articles by Navar, L. G.
Submitted on June 21, 2007
Accepted on November 2, 2007

Purinergic Receptors Contribute to Early Mesangial Cell Transformation and Renal Vessel Hypertrophy during Angiotensin II-Induced Hypertension

Miguel L Graciano1*, Akira Nishiyama2, Keith E Jackson3, Dale M Seth1, Rudy M. Ortiz1, Minolfa Prieto-Carrasquero1, Hiroyuki Kobori1, and L. Gabriel Navar4

1 Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, United States
2 Pharmacology, Kagawa Medical University, Kagawa, Japan
3 Department of Basic Pharmaceutical Sciences, University of Louisiana at Monroe, Monroe, Louisiana, United States
4 Department of Physiology, Tulane University School of Medicine, New Orleans,, Louisiana, United States

* To whom correspondence should be addressed. E-mail: miglugra{at}terra.com.br.

Chronic Ang II infusions lead to increases in intrarenal Ang II levels, hypertension and tissue injury. Increased blood pressure also elicits increases in renal interstitial fluid (RIF) ATP concentrations which stimulates cell proliferation. We evaluated the contribution of purinergic receptor activation to Ang II induced renal injury in rats by treating with clopidogrel, a P2Y12 receptor blocker, or with PPADS, a non-selective P2 receptor blocker. Alpha-actin expression in mesangial cells, afferent arteriolar wall thickness (AAWT), cortical cell proliferation, and macrophage infiltration were used as early markers of renal injury. Clopidogrel and PPADS did not alter blood pressure, renin or kidney Ang II content. Alpha-actin expression increased from control of 0.6±0.4% of mesangial area to 6.3±1.9% in Ang II infused rats and this response was prevented by clopidogrel (0.4±0.2%) and PPADS. The increase in AAWT from 4.7±0.1mm to 6.0±0.1mm in Ang II rats was also prevented by clopidogrel (4.8±0.1mm) and PPADS. Ang II infusion led to interstitial macrophage infiltration (105±16 cell/mm2 vs 62±4 cell/mm2) and tubular proliferation (71±15 vs 20±4 cell/mm2) and these effects were prevented by clopidogrel (52±4 cell/mm2 and 36±3 cell/mm2) and PPADS. RIF ATP levels were higher in Ang II infused rats than in control rats (11.8±1.9 nmol/L vs 5.6±0.6 nmol/L, p < 0.05). The results suggest that activation of vascular and glomerular purinergic P2 receptors may contribute to the mesangial cell transformation, renal inflammation and vascular hypertrophy observed in Ang II dependent hypertension.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.